Guidelines

New guidance on alcohol and health from the Canadian Centre on Substance Use and Addiction

New guidance on alcohol and health from the Canadian Centre on Substance Use and Addiction

By Dr. Paxton Bach on March 12, 2024

The new Canadian guideline situates alcohol-related harms along a continuum, recognizing that negative health and social consequences of alcohol can arise even at rates previously consistent with low risk.

Man sitting on toilet

Changing the game for Acute Infectious Diarrhea — IDP for the win!

By Dr. Ken Tan, Dr. Julia Stewart, Dr. Doug McTaggart, Dr. Sandra Lee, Chase Simms (MPH) on September 26, 2023

A new laboratory test has been introduced in BC: the Infectious Diarrhea Panel (IDP). This combines the previous three tests with a single-specimen test, and replaces the stool C&S and O&P in BC. Note, however, that standalone C. difficile tests are still available.

Identifying and treating iron deficiency in patients hospitalized for heart failure

Identifying and treating iron deficiency in patients hospitalized for heart failure

By Hans Haag and Dr. Ricky Turgeon on July 5, 2023

Heart failure is the third leading cause of hospitalization in Canada and leads to readmission in 1 in 5 patients within 30 days after discharge. Iron deficiency (with or without anemia) is an important comorbidity in patients with HF and is associated with worse outcomes. Assess iron deficiency for all patients with HFrEF and HFmrEF admitted for acute HF.

World Hepatitis Day

Hepatitis C birth cohort testing

By Drs. Mel Krajden and Jim Gray on July 28, 2022

WHO observes July 28th as World Hepatitis Day and aims to eliminate Hepatitis B and C by 2030. The Pan-Canadian Sexually Transmitted and Blood-Borne Infections (STBBI) Framework for Action released in 2018 echoes this goal and calls for 80% of eligible people in Canada to receive hepatitis C treatment by 2030. In order to achieve these goals by 2030, high rates of testing and diagnosis are essential. New HCV therapies are well tolerated, require 8–12 weeks of treatment, are publicly funded in BC, and have cure rates of about 95%.

Blood-pressure

Comparing intensive versus standard blood-pressure control: The SPRINT Trial

By Drs. Christopher Cheung and Kenneth Gin on June 22, 2016

Hypertension affects over 1 in 5 Canadians and is one of the leading causes of cardiovascular disease, including coronary artery disease and heart failure. Uncontrolled hypertension is a risk factor for stroke (both ischemic and hemorrhagic), retinopathy, chronic kidney disease (CKD), and peripheral vascular disease. Epidemiologic studies show that the risk of cardiovascular disease increases above a blood pressure of 115/75 mmHg.

Visit UBC CPD at ubccpd.ca

UBC CPD website

View all CPD learning activities: virtual, in-person and hybrid conferences, workshops, webinars, online modules, customized community courses, simulation hands-on courses, coaching, mentoring, personalized learning, recordings, and more.

Visit UBC CPD ↗

This field is for validation purposes and should be left unchanged.